| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.2M | -42.2% |
| R&D Expense | $56.5M | +16.9% |
| SG&A Expense | $33.3M | +33.8% |
| Operating Income | -$69.4M | -160.5% |
| Pre-tax Income | -$64.4M | -147.0% |
| Income Tax | -$13.7M | -268.8% |
| Net Income | -$50.6M | -126.6% |
| EPS (Basic) | -$0.51 | -96.2% |
| EPS (Diluted) | -$0.51 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | -51.0% |
| Accounts Receivable | $3.8M | -87.3% |
| Current Assets | $94.9M | -24.0% |
| Total Assets | $375.2M | -10.9% |
| Current Liabilities | $23.1M | -11.2% |
| Total Liabilities | $60.6M | -24.0% |
| Stockholders' Equity | $314.6M | -7.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.3M | +165.4% |
| Capital Expenditures | $1.6M | -90.4% |
| Investing Cash Flow | -$18.4M | +74.9% |
| Financing Cash Flow | -$892K | -100.8% |
| Free Cash Flow | $703K | +103.4% |
| -96.2% |